About Vineet Jindal
Form D filings for Secretome Therapeutics in 2023 list Vineet Jindal as chief executive officer and director.
Vineet Jindal first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vineet Jindal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vineet Jindal works with at each company, as listed on that company's latest Form D.
Secretome Therapeutics, Inc. · Form D, Feb 2, 2023